New WHO guidelines for cancer pain in adults and adolescents
Open Access
- 23 June 2021
- journal article
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (2), 90-108
- https://doi.org/10.17709/2410-1893-2021-8-2-9
Abstract
In this article we performed publication analysis devoted to pain medicine in oncology during anticancer therapy and in palliative setting. Until recently, the main WHO guidelines for pain management in oncology were the recommendations of 1996, which included only pain relievers, as well as adjuvant and symptomatic drugs, which were applied according to the WHO analgesic ladder. These recommendations were based on the collective expert opinion of leading clinicians and scientists. The new WHO clinical guidelines were published in 2019. They are based on the principles of evidence-based medicine, including modern concepts of the etiology and pathogenesis of tumor pain syndrome. This recommendations contain sections on the analgesic efficacy of radiation therapy and antitumor drug therapy. The new WHO recommendations have not yet been published in Russian and are not sufficiently available for a wide range of oncologists and palliative specialists in our country. The purpose of this publication is to present within one volume a concise but complete and comprehensible discussion of the latest trends in pain therapy in oncology, published by WHO experts.Keywords
This publication has 17 references indexed in Scilit:
- Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-AnalysisJournal of Pain and Symptom Management, 2016
- Identification and Management of Chronic Pain in Primary Care: a ReviewCurrent Psychiatry Reports, 2016
- Buprenorphine for treating cancer painEmergencias, 2015
- Radiation therapy for the management of painful bone metastases: Results from a randomized trialReports of Practical Oncology and Radiotherapy, 2014
- A Review of the Cost Effectiveness of Bisphosphonates in the Treatment of Post-Menopausal Osteoporosis in SwitzerlandApplied Health Economics and Health Policy, 2011
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyThe Lancet, 2011
- Opioid Inaccessibility and Its Human Consequences: Reports From the FieldJournal of Pain & Palliative Care Pharmacotherapy, 2010
- Opioid switching: A systematic and critical reviewCancer Treatment Reviews, 2006
- Transdermal opioids for cancer painHealth and Quality of Life Outcomes, 2006
- Breakthrough pain: definition, prevalence and characteristicsPain, 1990